From April 1, 2024 to June 28, 2024, the company has repurchased 386,083 shares, representing 4.19% for KRW 1,624.45 million. With this, the company has completed the repurchase of 436,083 shares, representing 4.73% for KRW 1,819 million under the buyback announced on March 26, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4,000 KRW | -0.12% |
|
-9.91% | -2.20% |
1st Jan change | Capi. | |
---|---|---|
-2.20% | 26.73M | |
+17.12% | 7.13B | |
+10.60% | 3.62B | |
+76.62% | 2.33B | |
+4.90% | 2.28B | |
+6.07% | 2.24B | |
+20.48% | 2.21B | |
+6.54% | 1.79B | |
+30.77% | 1.66B | |
+0.19% | 1.6B |
- Stock Market
- Equities
- A318160 Stock
- News Cell Bio Human Tech Co., Ltd
- Tranche Update on Cell Bio Human Tech Co., Ltd's Equity Buyback Plan announced on March 26, 2024.